Screening Extended-spectrum β-Lactamase Production in Enterobacter cloacae and Serratia marcescens Using Antibiogram-based Methods

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 1, 2010, Pages 26-34

  Su, Po An ^a   Wu, Lii Tzu ^b   Cheng, Kuo Chen ^a   Ko, Wen Chien ^c   Chuang, Yin Ching ^a   Yu, Wen Liang ^a,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

antibiogram; Enterobacter cloacae; extended spectrum lactamases; resistance; Serratia marcescens

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 3; BETA LACTAMASE SHV; BETA LACTAMASE SHV 12; BETA LACTAMASE SRT; BETA LACTAMASE TEM; BETA LACTAMASE TEM 1; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; FLOMOXEF; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA LACTAMASE AMPC GENE; BETA LACTAMASE CTX M 14 GENE; BETA LACTAMASE CTX M 3 GENE; BETA LACTAMASE SHV 12 GENE; BETA LACTAMASE SRT GENE; BETA LACTAMASE TEM GENE; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; ENTEROBACTER CLOACAE; ENZYME SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALIDITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERRATIA MARCESCENS; TAIWAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTER CLOACAE; HUMANS; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; SERRATIA MARCESCENS; TAIWAN;

EID: 77949555693     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60004-7     Document Type: Article

References (33)

1. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39 (1995) 1211-1233
2. Jacoby G.A. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 11 (1997) 875-887
3. Knothe H., Shah P., Krcmery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole, and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 6 (1983) 315-317
4. De Champs C., Sirot D., Chanal C., Bonnet R., and Sirot J. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrob Agents Chemother 44 (2000) 3177-3179
5. Tzelepi E., Giakkoupi P., Sofianou D., Loukova V., Kemeroglou A., and Tsakris A. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 38 (2000) 542-546
6. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14 (2001) 933-951
7. Thomson K.S. Controversies about extended-spectrum and AmpC β-lactamases. Emerg Infect Dis 7 (2001) 333-336
8. Bell J.M., Turnidge J.D., Jones R.N., and SENTRY Asia-Pacific Participants. Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 3989-3993
9. Park Y.J., Park S.Y., Oh E.J., Park J.J., Lee K.Y., Woo G.J., et al. Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 51 (2005) 265-269
10. Lindberg F., and Normark S. Contribution of chromosomal β-lactamases to β-lactam resistance in enterobacteria. Rev Infect Dis 8 (1986) S292-S304
11. Lindberg F., and Normark S. Common mechanism of ampC β-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 β-lactamase gene. J Bacteriol 169 (1987) 758-763
12. Normark S., Lindquist S., and Lindberg F. Chromosomal β-lactam resistance in enterobacteria. Scand J Infect Dis 49 (1986) S38-S45
13. Jarlier V., Nicolas M.H., Fournier G., and Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988) 867-878
14. Bedenic B., Randegger C., Boras A., and Haechler H. Comparison of five different methods for detection of SHV extended-spectrum β-lactamases. J Chemother 13 (2001) 24-33
15. De Gheldre Y., Avesani V., Berhin C., Delmee M., and Glupczynski Y. Evaluation of Oxoid combination discs for detection of extended-spectrum β-lactamases. J Antimicrob Chemother 52 (2003) 591-597
16. th Informational supplement M100-S15. Wayne (PA): NCCLS, 2005.
17. th Informational supplement M100-S15. Wayne (PA): NCCLS, 2005.
18. Wu T.L., Chia J.H., Su L.H., Kuo A.J., Chu C., and Chiu C.H. Dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol 41 (2003) 4836-4838
19. Liu C.P., Wang N.Y., Lee C.M., Weng L.C., Tseng H.K., Liu C.W., et al. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multi resistant isolates in a medical centre. J Hosp Infect 58 (2004) 63-77
20. Ma L., Chang F.Y., Fung C.P., Chen T.L., Lin J.C., Lu P.L., et al. Variety of TEM-, SHV-, and CTX-M-type β-lactamases present in recent clinical isolates of Escherichia coli, Klebsillella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist 11 (2005) 31-39
21. Chia J.H., Chu C., Su L.H., Chiu C.H., Kuo A.J., Sun C.F., et al. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M β-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. J Clin Microbiol 43 (2005) 4486-4491
22. Yu W.L., Cheng K.C., Chi C.H., Chen H.E., Chuang Y.C., and Wu L.T. Characterization and molecular epidemiology of extended-spectrum β-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Clin Microbiol Infect 12 (2006) 579-582
23. Yu W.L., Wu L.T., Pfaller M.A., Winokur P.L., and Jones R.N. Confirmation of extended-spectrum β-lactamase-producing Serratia marcescens: preliminary report from Taiwan. Diagn Microbiol Infect Dis 45 (2003) 221-224
24. Wu L.T., Tsou M.F., Wu H.J., Chen H.E., Chuang Y.C., and Yu W.L. Survey of CTX-M-3 extended-spectrum β-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan. Diagn Microbiol Infect Dis 49 (2004) 125-129
25. Cheng K.C., Chuang Y.C., Wu L.T., Huang G.C., and Yu W.L. Clinical experiences of the infections caused by extended-spectrum β-lactamase-producing Serratia marcescens at a medical center in Taiwan. Jpn J Infect Dis 59 (2006) 147-152
26. Ma L., Ishii Y., Chang F.Y., Yamaguchi K., Ho M., and Siu L.K. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum β-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 46 (2002) 1985-1988
27. Lee S.H., Kim J.Y., Shin S.H., An Y.J., Choi Y.W., Jung Y.C., et al. Dissemination of SHV-12 and characterization of new AmpC-type β-lactamase genes among clinical isolates of enterobacter species in Korea. J Clin Microbiol 41 (2003) 2477-2482
28. Nationl Center for Biotechnology Information. Available at: http:www.ncbi.nlm.nih.gov [Date accessed: August 5, 2005]
29. Pai H., Hong J.Y., Byeon J.H., Kim Y.K., and Lee H.J. High prevalence of extended-spectrum β-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob Agents Chemother 48 (2004) 3159-3161
30. Hoffmann H., Sturenburg E., Heesemann J., and Roggenkamp A. Prevalence of extended-spectrum β-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Clin Microbiol Infect 12 (2006) 322-330
31. Szabó D., Bonomo R.A., Silveira F., Pasculle A.W., Baxter C., Linden P.K., et al. SHV-type extended-spectrum β-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacae. J Clin Microbiol 43 (2005) 5058-5064
32. Jacoby G.A., and Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 34 (1990) 858-862
33. Thomson K.S., and Moland E.S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 45 (2001) 3548-3554